Status:
RECRUITING
Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-80 years
Brief Summary
1. Explore VOCs indicators that can effectively distinguish between benign and malignant breast diseases. 2. The accuracy of VOCs indicators and ultrasound 4a/4b/4c diagnosis will be compared in deter...
Detailed Description
Inclusion Criteria: Ultrasound examination within 3 months clearly indicates that breast lesions are BI-RADs4a/4b/4c Surgical treatment within one week after Exhaled VOC test informed consent form sh...
Eligibility Criteria
Inclusion
- Ultrasound examination within 3 months clearly indicates that breast lesions are BI-RADs4a/4b/4c
- Surgical treatment within one week after Exhaled VOC test
- informed consent form should be signed
Exclusion
- Male
- Women who have been diagnosed as breast cancer by puncture
- Individuals with unclear BI-RADs level information by breast ultrasound, including but not limited to BI-RADs 4/3-4a/4a-b/4b-c
- Pregnant or lactating women
- A positive smoking history within one year
- Medical history of malignant tumor, including but not limited to breast cancer (excluding skin basal cell carcinoma)
- The past history of metabolic diseases, including diabetes, gout, etc
- Respiratory diseases that have been clearly diagnosed in the past, such as asthma and chronic obstructive pulmonary emphysema, are not suitable for participation in the study
- Previously diagnosed digestive system diseases, such as Helicobacter pylori positivity and gastric ulcers, are not suitable for participation in the study
- Combination application of drugs related to the treatment of elderly dementia
- Possible cases which researchers believe it is not suitable for this clinical research
Key Trial Info
Start Date :
September 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
168 Patients enrolled
Trial Details
Trial ID
NCT06489158
Start Date
September 9 2024
End Date
December 31 2025
Last Update
September 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
41 Damucang Hutong, Xicheng District
Beijing, Beijing Municipality, China, 100032